Translocations involving MUM1 are rare in diffuse large B-cell lymphoma

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 2, 2010, Pages 109-112

  Hunt, Kristin E ^a   Hall, Bryan ^a   Reichard, Kaaren K ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b TRICORE REFERENCE LABORATORIES   (United States)

Author keywords

, MUM1; DLBCL; FISH; Lymphoma

Indexed keywords

CD10 ANTIBODY; CD138 ANTIBODY; CD20 ANTIBODY; CD3 ANTIBODY; CELL ANTIBODY; INTERFERON REGULATORY FACTOR 4; PROTEIN BCL 2; PROTEIN BCL 6; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CELL ACTIVATION; CHROMOSOME 6; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE PROBE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MOLECULAR CLONING; MULTIPLE MYELOMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCORING SYSTEM; TISSUE MICROARRAY; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CHILD; CHILD, PRESCHOOL; FEMALE; GERMINAL CENTER; HUMANS; IN SITU HYBRIDIZATION; INTERFERON REGULATORY FACTORS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSLOCATION, GENETIC;

EID: 77649121081     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31817fa43c     Document Type: Article

References (17)

1. Jaffe ES. Histopathology of the non-Hodgkin's lymphomas and Hodgkin's disease. In: Canellos GP, Lister TA, Sklar JL, eds. The Lymphomas. 1st ed. Philadelphia: W.B. Saunders; 1998:77-106.
2. Lossos IS. Molecular pathogenesis of diffuse large B-cell lymphoma. J Clin Oncol. 2005;23:6351-6357.
3. Alizadeh AA, Eisen MB, Davis RE, et al.. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503-511.
4. Rosenwald A, Wright G, Chan WC, et al.. The use of molecular profiling to predict survival after chemotherapy for diffuse large- B-cell lymphoma. N Engl J Med. 2002;346:1937-1947.
5. Shipp MA, Ross KN, Tamayo P, et al.. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002;8:68-74.
6. Tagawa H, Suguro M, Tsuzuki S, et al.. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Blood. 2005;106:1770-1777.
7. Berglund M, Thunberg U, Amini RM, et al.. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mod Pathol. 2005;18:1113-1120.
8. Zinzani PL, Dirnhofer S, Sabattini E, et al.. Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. Haematologica. 2005; 90:341-347.
9. Colomo L, Lopez-Guillermo A, Perales M, et al.. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood. 2003;101:78-84.
10. Chang CC, McClintock S, Cleveland RP, et al.. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol. 2004;28:464-470.
11. Hans CP, Weisenburger DD, Greiner TC, et al.. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103: 275-282.
12. Falini B, Fizzotti M, Pucciarini A, et al.. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood. 2000; 95:2084-2092.
13. Yoshida S, Nakazawa N, Iida S, et al.. Detection of MUM1/IRF4- IgH fusion in multiple myeloma. Leukemia. 1999;13:1812-1816.
14. Iida S, Rao PH, Butler M, et al.. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet. 1997;17:226-230.
15. Uranishi M, Iida S, Sanda T, et al.. Multiple myeloma oncogene 1 (MUM1)/interferon regulatory factor 4 (IRF4) upregulates monokine induced by interferon-c (MIG) gene expression in B-cell malignancy. Leukemia. 2005;19:1471-1478.
16. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al., eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001: 171-174.
17. Barrans SL, Carter I, Owen RG, et al.. Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood. 2002;99:1136-1143.